These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1661161

  • 1. Differentiation of a mouse neuroblastoma variant cell line whose ornithine decarboxylase gene has been amplified.
    Chen ZP, Chen KY.
    Biochim Biophys Acta; 1991 Dec 03; 1133(1):1-8. PubMed ID: 1661161
    [Abstract] [Full Text] [Related]

  • 2. Changes of ornithine decarboxylase activity and polyamine content upon differentiation of mouse NB-15 neuroblastoma cells.
    Chen KY, Presepe V, Parken N, Liu AY.
    J Cell Physiol; 1982 Mar 03; 110(3):285-90. PubMed ID: 6282899
    [Abstract] [Full Text] [Related]

  • 3. Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells.
    Chen KY, Nau D, Liu AY.
    Cancer Res; 1983 Jun 03; 43(6):2812-8. PubMed ID: 6303569
    [Abstract] [Full Text] [Related]

  • 4. Long-term reduction of amplified ornithine decarboxylase sequences in human myeloma cells.
    Wahlfors J, Myöhänen S, Korhonen VP, Alhonen L, Jänne J.
    Biochem J; 1995 Aug 15; 310 ( Pt 1)(Pt 1):299-303. PubMed ID: 7646459
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
    Casero RA, Go B, Theiss HW, Smith J, Baylin SB, Luk GD.
    Cancer Res; 1987 Aug 01; 47(15):3964-7. PubMed ID: 3038303
    [Abstract] [Full Text] [Related]

  • 6. Growth regulatory effects of cyclic AMP and polyamine depletion are dissociable in cultured mouse lymphoma cells.
    McConlogue LC, Marton LJ, Coffino P.
    J Cell Biol; 1983 Mar 01; 96(3):762-7. PubMed ID: 6300139
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the differentiation of 3T3-L1 cells by interferon-beta and difluoromethyl ornithine.
    Taylor JL, Turo KA, McCann PP, Grossberg SE.
    J Biol Regul Homeost Agents; 1988 Mar 01; 2(1):19-24. PubMed ID: 3140600
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the differentiation of 3T3-L1 cells by interferon-beta and difluoromethyl ornithine.
    Taylor JL, Turo KA, McCann PP, Grossberg SE.
    J Biol Regul Homeost Agents; 1988 Mar 01; 2(2):99-104. PubMed ID: 3142219
    [Abstract] [Full Text] [Related]

  • 9. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
    Stoscheck CM, Erwin BG, Florini JR, Richman RA, Pegg AE.
    J Cell Physiol; 1982 Feb 01; 110(2):161-8. PubMed ID: 6802862
    [Abstract] [Full Text] [Related]

  • 10. Multiple regulation of ornithine decarboxylase in enzyme-overproducing cells.
    Kameji T, Hayashi S, Hoshino K, Kakinuma Y, Igarashi K.
    Biochem J; 1993 Jan 15; 289 ( Pt 2)(Pt 2):581-6. PubMed ID: 8424799
    [Abstract] [Full Text] [Related]

  • 11. Cadaverine supplementation during a chronic exposure to difluoromethylornithine allows an overexpression, but prevents gene amplification, of ornithine decarboxylase in L1210 mouse leukaemia cells.
    Alhonen-Hongisto L, Hirvonen A, Sinervirta R, Jänne J.
    Biochem J; 1987 Nov 01; 247(3):651-5. PubMed ID: 3122732
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
    Oredsson SM, Billgren M, Heby O.
    Eur J Cell Biol; 1985 Sep 01; 38(2):335-43. PubMed ID: 3930245
    [Abstract] [Full Text] [Related]

  • 14. Relationship between ornithine decarboxylase activity and hexamethylene bisacetamide-induced differentiation of murine erythroleukemia cells.
    Meilhoc E, Moutin MJ, Romani BH, Osborne HB.
    Exp Cell Res; 1986 Jan 01; 162(1):142-50. PubMed ID: 3079592
    [Abstract] [Full Text] [Related]

  • 15. Polyamines in 1 alpha, 25-dihydroxycholecalciferol-induced differentiation of human promyelocytic leukemia cells, HL-60.
    Inaba M, Otani S, Matsui-Yuasa I, Yukioka K, Nishizawa Y, Ishimura E, Morisada S, Yukioka M, Morisawa S, Morii H.
    Endocrinology; 1986 May 01; 118(5):1849-55. PubMed ID: 3084209
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
    Saulnier Sholler GL, Gerner EW, Bergendahl G, MacArthur RB, VanderWerff A, Ashikaga T, Bond JP, Ferguson W, Roberts W, Wada RK, Eslin D, Kraveka JM, Kaplan J, Mitchell D, Parikh NS, Neville K, Sender L, Higgins T, Kawakita M, Hiramatsu K, Moriya SS, Bachmann AS.
    PLoS One; 2015 May 01; 10(5):e0127246. PubMed ID: 26018967
    [Abstract] [Full Text] [Related]

  • 19. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K, Zhao P, Kendzicky A, Yco LP, McClung H, Gerner E, Burns M, Bachmann AS, Sholler G.
    Int J Cancer; 2013 Sep 15; 133(6):1323-33. PubMed ID: 23457004
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
    Gawel-Thompson KJ, Greene RM.
    J Cell Physiol; 1989 Aug 15; 140(2):359-70. PubMed ID: 2501317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.